PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study.
Giulio FrancoliniMarco BaniniVanessa Di CataldoBeatrice DettiSaverio CainiMauro LoiGabriele SimontacchiIsacco DesideriDaniela GretoMarianna ValzanoManuele RoghiSergio SerniLuca VaggelliViola SalvestriniLuca VisaniCarlotta BecheriniEmanuela OlmettoCiro FranzeseDavide BaldacciniMarta ScorsettiMartina SolliniArturo ChitiIcro MeattiniRichard K ValicentiLorenzo LiviPublished in: The Prostate (2023)
PSICHE trial constitute a useful platform to collect data within a clinical framework where modern imaging and metastasis-directed therapy are integrated.
Keyphrases
- pet ct
- phase iii
- study protocol
- phase ii
- positron emission tomography
- clinical trial
- high resolution
- electronic health record
- randomized controlled trial
- stem cells
- high throughput
- big data
- loop mediated isothermal amplification
- robot assisted
- free survival
- replacement therapy
- label free
- cell therapy
- deep learning
- machine learning
- benign prostatic hyperplasia